Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-exposure Prophylaxis”

176 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 176 results

Large-scale testing (Phase 3)Study completedNCT01114425
What this trial is testing

Safety Study of Isentress® + Truvada® in Post-exposure Treatment of HIV Infection

Who this might be right for
HIV Infections
Groupe d'Etude sur le Risque d'Exposition des Soignants aux Agents Infectieux 149
Testing effectiveness (Phase 2)Study completedNCT01140880
What this trial is testing

Biobehavioral Interventions for HIV-negative, Stimulant Using Men Who Have Sex With Men

Who this might be right for
HIV SeroconversionStimulant Abuse
Friends Research Institute, Inc. 170
Not applicableStudy completedNCT05684185
What this trial is testing

Immunogenicity Assessment of Subjects Receiving Rabies Post-exposure Prophylaxis in Cambodia

Who this might be right for
Rabies Post-exposure Prophylaxis
Institut Pasteur du Cambodge 215
Large-scale testing (Phase 3)WithdrawnNCT04397328
What this trial is testing

COVID-19 PEP- High-risk Individuals in Long-term and Specialized Care - Canada

Who this might be right for
COVID-19
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Not applicableUnknownNCT05438953
What this trial is testing

Follow-up of People at Risk of Monkeypox Infection: a Prospective Cohort Study

Who this might be right for
Monkey PoxMonkey Diseases
Assistance Publique - Hôpitaux de Paris 164
Early research (Phase 1)WithdrawnNCT01593072
What this trial is testing

Assess the Safety, Tolerability and Pharmacokinetics of AVI-7537 in Healthy Adult Volunteers

Who this might be right for
Ebola Hemorrhagic Fever
Sarepta Therapeutics, Inc.
Large-scale testing (Phase 3)WithdrawnNCT04342156
What this trial is testing

Safety And Efficacy Of Hydroxychloroquine For At Risk Population (SHARP) Against COVID-19

Who this might be right for
Coronavirus InfectionHydroxychloroquine Adverse Reaction
Tan Tock Seng Hospital
Large-scale testing (Phase 3)Study completedNCT04594551
What this trial is testing

Study of Purified Vero Rabies Vaccine Compared With a Reference Rabies Vaccine as Simulated Rabies Post-Exposure Prophylaxis in Adults in Thaïland

Who this might be right for
Rabies (Healthy Volunteers)
Sanofi Pasteur, a Sanofi Company 201
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07055880
What this trial is testing

Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)

Who this might be right for
Rabies
Sinovac Biotech Co., Ltd 120
Testing effectiveness (Phase 2)Looking for participantsNCT05886816
What this trial is testing

Mitoquinone/mitoquinol Mesylate As Oral and Safe Postexposure Prophylaxis for Covid-19

Who this might be right for
SARS-CoV InfectionCOVID-19
University of Texas Southwestern Medical Center 112
Not applicableStudy completedNCT04656522
What this trial is testing

Comic Intervention for Sexual Violence Prevention and Post-rape Care

Who this might be right for
Knowledge, Attitudes, PracticePost-exposure Prophylaxis
University of Toronto 100
Large-scale testing (Phase 3)Study completedNCT03189537
What this trial is testing

Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections

Who this might be right for
Influenza, HumanAcute Respiratory InfectionCommon Cold+2 more
Valenta Pharm JSC 400
Post-approval studies (Phase 4)Study completedNCT00594646
What this trial is testing

HIV Non Occupational Post-Exposure Prophylaxis (PEP)

Who this might be right for
HIV Infections
Fenway Community Health 100
Not applicableStudy completedNCT01177488
What this trial is testing

Innovative Service Delivery for Secondary Prevention of PTSD

Who this might be right for
PTSD
Charleston Research Institute 280
Post-approval studies (Phase 4)Active Not RecruitingNCT06485154
What this trial is testing

Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial

Who this might be right for
HIV Prevention
University of Witwatersrand, South Africa 100
Not applicableUnknownNCT03695302
What this trial is testing

Knowledge , Attitude and Practice (KAP) of Fifth Year Undergraduate Dental Students on Post Exposure Prophylaxis

Who this might be right for
Occupational Exposure
Cairo University 400
Post-approval studies (Phase 4)Study completedNCT02211690
What this trial is testing

The Tolerability of, and Adherence to, Dolutegravir With Co-formulated Tenofovir-emtricitabine for HIV Non-occupational Post-exposure Prophylaxis

Who this might be right for
Human Immunodeficiency Virus
Andrew Carr 100
Large-scale testing (Phase 3)Study completedNCT01622062
What this trial is testing

Immunogenicity and Safety of Verorab® in a "One-week" Intradermal Post-exposure Prophylaxis Regimen

Who this might be right for
Rabies
Sanofi Pasteur, a Sanofi Company 600
Early research (Phase 1)Study completedNCT01353027
What this trial is testing

Safety Study of Single Administration Post-Exposure Prophylaxis Treatment for Ebola Virus

Who this might be right for
Ebola Hemorrhagic Fever
Sarepta Therapeutics, Inc. 30
Large-scale testing (Phase 3)UnknownNCT05667974
What this trial is testing

Evaluate a PIKA Rabies Vaccine（Vero Cell）for Human Use,Freeze-dried

Who this might be right for
RabiesPrevention
Yisheng Biopharma (Singapore) Pte. Ltd. 4,500
Load More Results